Where does Ifom —FONDAZIONE Istituto Firc DI Oncologia Molecolare rank among US patent assignees?

According to USPTO PatentsView (2015–2025 granted utility patents), Ifom —FONDAZIONE Istituto Firc DI Oncologia Molecolare ranks #47,597 of 49,997 assignees by granted-patent volume, the same sort as the companies listing and top-holders ranking. See /methodology/#corpus-placement.

Is Ifom —FONDAZIONE Istituto Firc DI Oncologia Molecolare's patent grant rate increasing or decreasing?

Ifom —FONDAZIONE Istituto Firc DI Oncologia Molecolare's recent grant velocity is -50% compared to the prior five-year period (grant years, not application filing dates). Grant activity has slowed relative to earlier years.

What does claim depth mean for Ifom —FONDAZIONE Istituto Firc DI Oncologia Molecolare's patents?

Ifom —FONDAZIONE Istituto Firc DI Oncologia Molecolare's patents average 15.2 claims each. This is an aggregate descriptive count from the grant record; it does not establish claim scope, legal strength, enforceability, or design-around risk.

USPTO 2015–2025 USPTO PatentsView Foreign Corporation

Ifom —FONDAZIONE Istituto Firc DI Oncologia Molecolare

Q: How many patents does Ifom —FONDAZIONE Istituto Firc DI Oncologia Molecolare hold?

Ifom —FONDAZIONE Istituto Firc DI Oncologia Molecolare holds 5 US utility patents granted between 2017 and 2025, spanning 6 technology areas.

Q: What is Ifom —FONDAZIONE Istituto Firc DI Oncologia Molecolare's Innovation Score?

Ifom —FONDAZIONE Istituto Firc DI Oncologia Molecolare has an Innovation Score of 30.6 out of 100 (35th percentile of the corpus). This composite metric weighs portfolio volume (40%), grant velocity (20%), technology breadth (25%), and claim depth (15%).

Q: What technology areas does Ifom —FONDAZIONE Istituto Firc DI Oncologia Molecolare focus on?

Ifom —FONDAZIONE Istituto Firc DI Oncologia Molecolare's top technology area is A61P (Specific Therapeutic Activity OF Chemical Compounds OR Medicinal Preparations) with 4 patents. Grants appear in 6 CPC subclasses total.

Q: How is the Ifom —FONDAZIONE Istituto Firc DI Oncologia Molecolare patent data sourced?

All patent data comes from USPTO PatentsView, a public research dataset maintained by the United States Patent and Trademark Office covering US granted utility patents from 2015 to 2025.

USPTO PatentsView assignee record - 5 granted patents across 6 technology areas, recorded in grant years 2017–2025. Grant-trend analysis is cross-referenced to USPTO Patent Public Search; it does not measure application filings, current R&D, or legal strength. Primary class: A61P (Specific Therapeutic Activity OF Chemical Compounds OR Medicinal Preparations).

Compiled by PlainPatent · May 15, 2026

RSS updates for this company

Explore the portfolio See the ranking

The verdict

According to USPTO PatentsView, Ifom ranks #47,597 of 49,997 tracked US assignees by granted-patent volume, with 5 patents across 6 technology areas.

#47,597
of 49,997 US assignees by volume: 35th percentile
by Innovation Score (30.6/100): 15.2
avg claims per patent: -50%
grant velocity, last 5 yrs

USPTO PatentsView assignee plate

Corpus R47597 · Foreign Corporation #47,597 · 5 grants

GRANTS-MICRO · BOTTOM-DECILE · PHOTO-FINISH · CPC-NARROW · INNOV-THIN · CLAIMS-RICH · TYPE-FRNCORP · VEL-DROP · BOOK-FULL

GRANTS-MICRO 5 grants
BOTTOM-DECILE #47,597/49,997
PHOTO-FINISH Ie-cheng Technology…
CPC-NARROW A61P · 6 areas
INNOV-THIN 30.6/100
CLAIMS-RICH 15.2 claims/avg
TYPE-FRNCORP Foreign Corp
VEL-DROP -50% vel
BOOK-FULL 10/10 fields

Nearest grant-volume peer: Ie-cheng Technology (TIANJIN) Co., Ltd. (±0 grants)

Instrument codes from this assignee’s USPTO PatentsView grant sheet: volume band, corpus rank, photo-finish peer, lead CPC, Innovation Score, claim depth, assignee type, velocity, and book completeness. Not a USPTO rating of patent strength.

Qualcomm Incorporated · highest

85
Ifom —FONDAZIONE… · this assignee

31
3D Lighting… · lowest

7

What this shows Ifom's Innovation Score is 30.6/100 (35th percentile of the PatentsView-derived corpus). The chart places that score against the nearest Innovation Score peers plus corpus poles, not a reprint of the volume ranking.

Where Ifom's grants concentrate

Ifom —FONDAZIONE Istituto Firc DI Oncologia Molecolare is a focused PatentsView assignee: 6 CPC subclasses with 80% of grants classified under A61P (Specific Therapeutic Activity OF Chemical Compounds OR Medicinal Preparations). By volume, Ifom sits between Ie-cheng Technology (TIANJIN) Co., Ltd. and Iida Co., Ltd..

Ifom's three-year grant acceleration

Ifom —FONDAZIONE Istituto Firc DI Oncologia Molecolare shows 1 grants in 2022–2024 against only 1 in 2019–2021. That prior window is too thin for a growth multiple (rename and spin-out assignees look artificially high when the baseline is near zero), so PlainPatent withholds a ranked acceleration claim here.

Ie-cheng Technolo…

5
IEC Infrared Syst…

5
Ifa-

5
Ifly Holdings

5
IGL Pharma

5
IHI Rotating Mach…

5
IHI Shibaura Mach…

5
Iida

5
Ifom —Fondazione… ◀

5

What this shows Ifom holds 5 patents at rank #47,595, shown against the 8 assignees closest to it in grant volume rather than the industry's largest filers.

Companies ranked near Ifom

By rank, the assignees closest to #47,595 in granted patent volume.

Leaders in A61P (Specific Therapeutic Activity OF Chemical Compounds OR Me…)

Other assignees with the most granted patents in Ifom's primary technology class.

Ifom's Innovation Score vs. every tracked assignee

Composite of portfolio volume, grant velocity, technology breadth, and claim depth (0–100)

31 35th percentile higher than 35% of 49,997 US assignees

Each bar is a band; taller bars hold more US assignees. The dashed line + filled bar mark this entry. Hover or tap any bar for its full count, share, and where it sits relative to this entry.

Source USPTO PatentsView, PlainPatent Innovation Score · 2015–2025

USPTO utility patent grants by year · 2017–2025

Grants by year

Teal-shaded recent years (2020–present) versus the 2017–2019 baseline. Full figures in the table below.

View data table

Ifom —FONDAZIONE Istituto Firc DI Oncologia Molecolare patent grants by year, 2015–2025
Year	Patents Granted	Share of Period
2017	1	20.0%
2019	1	20.0%
2022	1	20.0%
2025partial year	2	40.0%

Which technologies does Ifom —FONDAZIONE Istituto Firc DI Oncologia Molecolare patent most?

A61P - Specific Therapeutic Activity OF Chemical Compounds OR Medicinal Preparations 4

C12N - Microorganisms OR ENZYMES; Compositions THEREOF; Propagating, Preserving, OR Maintaining MICROORGANISMS; Mutation OR Genetic ENGINEERING; Culture Media 3

C12Q - Measuring OR Testing Processes Involving Enzymes, Nucleic Acids OR Microorganisms ; Compositions OR Test Papers THEREFOR; Processes OF Preparing Such COMPOSITIONS; Condition-responsive Control IN Microbiological OR Enzymological Processes 2

C07D - Heterocyclic Compounds 1

A61K - Preparations FOR Medical, Dental OR Toiletry Purposes 1

C12M - Apparatus FOR Enzymology OR MICROBIOLOGY; Apparatus FOR Culturing Microorganisms FOR Producing Biomass, FOR Growing Cells OR FOR Obtaining Fermentation OR Metabolic Products, i.e. Bioreactors OR Fermenters 1

Top 6 of 6 technology areas

Where it ranks

Overall rank by patents

#47,597

of 49,997 tracked assignees

Innovation Score

30.6 out of 100

View all rankings →

Data Source

USPTO PatentsView, US granted patents 2015–2025

How is Innovation Score calculated?

What to do with this data

Ifom —FONDAZIONE Istituto Firc DI Oncologia Molecolare's patent record in context - here's where to go next.

Ifom —FONDAZIONE Istituto Firc DI Oncologia Molecolare's lead technology class is A61P (Specific Therapeutic Activity OF Chemical Compounds OR Medicinal Preparations), 80% of its portfolio - see every assignee active in that class. Explore A61P
Ranked #47,597 of 49,997 tracked assignees by patent volume - see the full leaderboard. See the ranking
Compare Ifom —FONDAZIONE Istituto Firc DI Oncologia Molecolare against Ie-cheng Technology (TIANJIN) Co., Ltd., an assignee filing at a similar volume. Compare portfolios
Innovation Score of 30.6/100 blends volume, velocity, technology breadth, and claim depth. How it's calculated

Figures reflect USPTO PatentsView grant data through May 2026; pending applications not yet granted are not counted.

Data sourced from USPTO PatentsView - official U.S. government patent data. See our methodology for computation details. Retrieved and formatted by PlainPatent

Disclaimer: This information is provided for informational purposes only and does not constitute professional advice. Data is sourced from the USPTO PatentsView database. Consult a qualified professional before making decisions based on this data.

Read our methodology - how this data is sourced, computed, and verified.

Data sources used on this page

USPTO PatentsView - the disambiguated bulk patent-grant, assignee, and CPC data this page's figures are derived from. patentsview.org
Cooperative Patent Classification (CPC) - the joint USPTO/EPO classification scheme used to group patents by technology area. cooperativepatentclassification.org
USPTO Patent Public Search - the official interface to verify the status of any individual patent. ppubs.uspto.gov

Compiled by PlainPatent, US Patent Intelligence Editorial Process · May 15, 2026

Every figure on PlainPatent is rendered directly from USPTO source data, no number is typed in by an editor. This page draws directly on USPTO source data, no figure is typed in by an editor. See our editorial standards & corrections policy, the methodology behind these numbers, or report a data error. Data current as of May 2026.